DMAT | XLB | DMAT / XLB | |
Gain YTD | 47.040 | 9.606 | 490% |
Net Assets | 5.53M | 5.48B | 0% |
Total Expense Ratio | 0.59 | 0.08 | 737% |
Turnover | 22.42 | 13.00 | 172% |
Yield | 1.09 | 1.85 | 59% |
Fund Existence | 4 years | 27 years | - |
DMAT | XLB | |
---|---|---|
RSI ODDS (%) | 2 days ago75% | N/A |
Stochastic ODDS (%) | 2 days ago87% | 2 days ago80% |
Momentum ODDS (%) | 2 days ago90% | 2 days ago85% |
MACD ODDS (%) | 2 days ago78% | 2 days ago84% |
TrendWeek ODDS (%) | 2 days ago85% | 2 days ago84% |
TrendMonth ODDS (%) | 2 days ago81% | 2 days ago81% |
Advances ODDS (%) | 8 days ago82% | 10 days ago86% |
Declines ODDS (%) | 17 days ago84% | 3 days ago84% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago82% |
Aroon ODDS (%) | 2 days ago81% | 2 days ago79% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FSMD | 44.21 | 0.56 | +1.28% |
Fidelity Small-Mid Multifactor ETF | |||
EUM | 22.51 | 0.08 | +0.36% |
ProShares Short MSCI Emerging Markets | |||
AWP | 3.97 | 0.01 | +0.25% |
abrdn Global Premier Properties Fund | |||
SMAP | 24.60 | N/A | N/A |
Amplify Small-Mid Cap Equity ETF | |||
SBIO | 36.15 | -0.01 | -0.03% |
ALPS Medical Breakthroughs ETF |
A.I.dvisor tells us that DMAT and ALB have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DMAT and ALB's prices will move in lockstep.
Ticker / NAME | Correlation To DMAT | 1D Price Change % | ||
---|---|---|---|---|
DMAT | 100% | -2.44% | ||
ALB - DMAT | 17% Poorly correlated | -1.05% | ||
AMS - DMAT | 12% Poorly correlated | +1.59% | ||
AMG - DMAT | 9% Poorly correlated | +1.04% | ||
NIC - DMAT | 6% Poorly correlated | +1.21% | ||
LAC - DMAT | 6% Poorly correlated | -2.45% | ||
More |
A.I.dvisor indicates that over the last year, XLB has been closely correlated with DD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLB jumps, then DD could also see price increases.